← Back to headlines
New ADHD Drug Awaiting FDA Approval Could Revolutionize Treatment
The FDA has prioritized a new drug for ADHD, developed by a Japanese pharmaceutical giant, which psychiatrists believe could significantly change existing pharmacotherapy options for patients.
26 Feb, 10:04 — 26 Feb, 10:04
ℹOnly 1 source covers this story
